134 related articles for article (PubMed ID: 6179814)
1. Studies on severe hepatic damage induced by galactosamine.
Ozeki T; Kan M; Yamagata S; Taoka Y
Gastroenterol Jpn; 1982 Apr; 17(2):87-92. PubMed ID: 6179814
[TBL] [Abstract][Full Text] [Related]
2. 45Calcium uptake during the transition from reversible to irreversible liver injury induced by D-galactosamine in vivo.
Schiessel C; Forsthove C; Keppler D
Hepatology; 1984; 4(5):855-61. PubMed ID: 6207090
[TBL] [Abstract][Full Text] [Related]
3. Metabolic studies in experimental liver disease resulting from D(+)-galactosamine administration.
Record CO; Alberti KG; Williamson DH
Biochem J; 1972 Nov; 130(1):37-44. PubMed ID: 4655444
[TBL] [Abstract][Full Text] [Related]
4. [Cyclic AMP- and ATP-mediated stimulation of DNA synthesis following partial hepatectomy by prostaglandin-E1 in D-galactosamine injured liver].
Shimura T; Miyazaki M; Koshikawa H; Takahashi O; Sugasawa H; Fujimoto S; Okui K
Nihon Geka Gakkai Zasshi; 1985 Dec; 86(12):1618-24. PubMed ID: 3003557
[TBL] [Abstract][Full Text] [Related]
5. Preventive effects of 5-fluorouridine and uridine on d-galactosamine-induced liver injury.
Holstege A; Anukarahanonta T; Yamamoto M; Koch HK; Kattermann R; Lesch R; Keppler D
Exp Mol Pathol; 1981 Apr; 34(2):170-82. PubMed ID: 6162676
[No Abstract] [Full Text] [Related]
6. The effect of fasting on galactosamine induced hepatitis in experimental animals.
Pickering RW
Arzneimittelforschung; 1977; 27(10):1992-6. PubMed ID: 579109
[TBL] [Abstract][Full Text] [Related]
7. The protective effect of polyriboinosinic acid-polyribocytidylic acid against the occurrence of galactosamine-induced liver cell injury in rat.
Sakakibara S; Shibayama Y; Ueda I; Kagamiyama H
Experientia; 1983 Feb; 39(2):174-6. PubMed ID: 6832294
[TBL] [Abstract][Full Text] [Related]
8. Prevention of galactosamine-induced hepatotoxicity in rats with fructose-1,6-diphosphate.
Markov AK; Farias LA; Bennett WS; Subramony C; Mihas AA
Pharmacology; 1991; 43(6):310-7. PubMed ID: 1686110
[TBL] [Abstract][Full Text] [Related]
9. Dietary wheat gluten alleviates the elevation of serum transaminase activities in D-galactosamine-injected rats.
Manabe A; Cheng CC; Egashira Y; Ohta T; Sanada H
J Nutr Sci Vitaminol (Tokyo); 1996 Apr; 42(2):121-32. PubMed ID: 8780970
[TBL] [Abstract][Full Text] [Related]
10. Effect of galactosamine on hepatic carbohydrate metabolism: protective role of fructose 1,6-bisphosphate.
De Oliveira JR; Rosa JL; Ambrosio S; Bartrons R
Hepatology; 1992 Jun; 15(6):1147-53. PubMed ID: 1317340
[TBL] [Abstract][Full Text] [Related]
11. Melatonin attenuates lipopolysaccharide (LPS)-induced apoptotic liver damage in D-galactosamine-sensitized mice.
Wang H; Xu DX; Lv JW; Ning H; Wei W
Toxicology; 2007 Jul; 237(1-3):49-57. PubMed ID: 17602819
[TBL] [Abstract][Full Text] [Related]
12. Hepatoprotective effect of germanium-containing Spirulina in rats with (D)-galactosamine- and lipopolysaccharide-induced hepatitis.
Yoshinari O; Shiojima Y; Igarashi K
Br J Nutr; 2014 Jan; 111(1):135-40. PubMed ID: 23768655
[TBL] [Abstract][Full Text] [Related]
13. Effect of carvacrol on hepatic marker enzymes and antioxidant status in D-galactosamine-induced hepatotoxicity in rats.
Aristatile B; Al-Numair KS; Veeramani C; Pugalendi KV
Fundam Clin Pharmacol; 2009 Dec; 23(6):757-65. PubMed ID: 19650854
[TBL] [Abstract][Full Text] [Related]
14. Effect of dietary L-glutamine on the hepatotoxic action of D-galactosamine in rats.
Katayama T; Cheng CC; Egashira Y; Ohta T; Sanada H
Biosci Biotechnol Biochem; 1996 Sep; 60(9):1425-9. PubMed ID: 8987589
[TBL] [Abstract][Full Text] [Related]
15. Modulation of hepatotoxicity by macrophages in the liver.
Shiratori Y; Kawase T; Shiina S; Okano K; Sugimoto T; Teraoka H; Matano S; Matsumoto K; Kamii K
Hepatology; 1988; 8(4):815-21. PubMed ID: 2839405
[TBL] [Abstract][Full Text] [Related]
16. Effect of ursodeoxycholic acid on biochemical parameters, hepatocyte proliferation and liver histology in galactosamine hepatitis in the rat.
Rudi J; Schlenker T; Raedsch R; Waldherr R; Zorn M; Stremmel W
Res Exp Med (Berl); 1995; 195(5):309-15. PubMed ID: 8579639
[TBL] [Abstract][Full Text] [Related]
17. Colchicine prevents D-galactosamine-induced hepatitis.
Mourelle M; Meza MA
J Hepatol; 1989 Mar; 8(2):165-72. PubMed ID: 2565925
[TBL] [Abstract][Full Text] [Related]
18. Effects of putrescine on D-galactosamine-induced acute liver failure in rats.
Nishiguchi S; Kuroki T; Takeda T; Nakajima S; Shiomi S; Seki S; Matsui-Yuasa I; Otani S; Kobayashi K
Hepatology; 1990 Aug; 12(2):348-53. PubMed ID: 2391073
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of the pretreatment and treatment with RhIL-11 on acute liver failure induced by D-galactosamine.
Nie XH; Han T; Ha FU; Liang N; Wang SH; Zhu ZY; Xiang HL
Eur Rev Med Pharmacol Sci; 2014; 18(8):1142-50. PubMed ID: 24817287
[TBL] [Abstract][Full Text] [Related]
20. Xanthine oxidase-derived reactive oxygen species contribute to the development of D-galactosamine-induced liver injury in rats.
Ohta Y; Matsura T; Kitagawa A; Tokunaga K; Yamada K
Free Radic Res; 2007 Feb; 41(2):135-44. PubMed ID: 17364939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
